- Issuer ticker
-
TEVA
- Reported as of
-
04 Nov 2026
- Net transaction value
-
-$1,095,567
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
06 Nov 2026, 16:01:54 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Dov Bergwerk
Filing notes and source
Key filing fact
Dov Bergwerk filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 06 Nov 2026.
Key facts
- This page summarizes Dov Bergwerk's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Nov 2026, 16:01.
Change
- Previous filing in this sequence was filed on 08 Oct 2026.
- Current net transaction value: -$1,095,567.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001997381
Primary reporting owner
Bergwerk Dov
- Relationship
-
Interim Cheif Legal Officer
- Address
- C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HA'NEVIA STREET, TEL AVIV, ISRAEL
- Signature
- /s/ Dov Bergwerk
- Signature date
- 06 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +17,505
- Change %
- +147%
- Price
-
$34.70*
- Shares after
- 29,448
- Date
- 04 Nov 2026
- Ownership
- Direct
TEVA
transaction
Ordinary Shares
Sale
- Transaction value
- -$730,309
- Shares
- -17,505
- Change %
- -59%
- Price
-
$41.72
- Shares after
- 11,943
- Date
- 04 Nov 2026
- Ownership
- Direct
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +8,755
- Change %
- +73%
- Price
-
$28.98*
- Shares after
- 20,698
- Date
- 04 Nov 2026
- Ownership
- Direct
TEVA
transaction
Ordinary Shares
Sale
- Transaction value
- -$365,259
- Shares
- -8,755
- Change %
- -42%
- Price
-
$41.72
- Shares after
- 11,943
- Date
- 04 Nov 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TEVA
transaction
Derivative
Stock Options (right to buy)
Options Exercise
- Transaction value
- Shares
- -17,505
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 04 Nov 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 17,505
- Exercise price
- $34.70
- Footnotes
- F1
TEVA
transaction
Derivative
Stock Options (right to buy)
Options Exercise
- Transaction value
- Shares
- -8,755
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 04 Nov 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 8,755
- Exercise price
- $28.98
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes